Context Therapeutics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNTX research report →
Companywww.contexttherapeutics.com
Context Therapeutics Inc. , a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers.
- CEO
- Martin A. Lehr
- IPO
- 2021
- Employees
- 12
- HQ
- Philadelphia, PA, US
Price Chart
Valuation
- Market Cap
- $204.89M
- P/E
- -5.28
- P/S
- 0.00
- P/B
- 4.07
- EV/EBITDA
- -3.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -59.95%
- ROIC
- -82.91%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-36,123,615 · -35.17%
- EPS
- $-0.38 · 17.39%
- Op Income
- $-39,702,631
- FCF YoY
- 9.87%
Performance & Tape
- 52W High
- $3.62
- 52W Low
- $0.49
- 50D MA
- $2.57
- 200D MA
- $1.67
- Beta
- 1.57
- Avg Volume
- 843.08K
Get TickerSpark's AI analysis on CNTX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 19, 26 | Levit Alex C. | other | 270,000 |
| Feb 19, 26 | Minai-Azary Jennifer Lynn | other | 275,000 |
| Feb 19, 26 | Chagin Karen Deborah | other | 290,000 |
| Feb 19, 26 | Lehr Martin A. | other | 815,000 |
| Jun 12, 25 | Pasternak Andy | other | 138,900 |
| Jun 12, 25 | Kantoff Philip W. | other | 123,500 |
| Jun 12, 25 | Smith Karen L. | other | 123,500 |
| Jun 12, 25 | Stacey Jennifer Evans | other | 123,500 |
| Jun 12, 25 | Walker Luke Nathaniel | other | 123,500 |
| Jun 12, 25 | West Linda | other | 123,500 |
Our CNTX Coverage
We haven't published any research on CNTX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CNTX Report →